Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Nature Communications
|
December 23, 2025
IL-33 expands plasma cells, disrupts germinal centers, and increases autoantibody production in mice
Eva Conde, Seblewongel Asrat, Andrea Vecchione, et al.
Cell Reports Methods
|
August 3, 2023
TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells
Seblewongel Asrat, Joseph C Devlin, Andrea Vecchione, et al.
Science Immunology
|
September 6, 2024
IgE plasma cells are transcriptionally and functionally distinct from other isotypes
Andrea Vecchione, Joseph C Devlin, Carley Tasker, et al.
Cytokine
|
December 8, 2022
IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline
George Scott, Seblewongel Asrat, Jeanne Allinne, et al.
Allergy
|
January 27, 2024
Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy
Matthew F Wipperman, Kaitlyn M Gayvert, Amanda Atanasio, et al.
The Journal of Allergy and Clinical Immunology
|
August 7, 2022
REGN1908/1909 prevented cat allergen-induced early asthmatic responses in an environmental exposure unit
Frederic J de Blay, Alina Gherasim, Nathalie Domis, et al.
The Journal of Allergy and Clinical Immunology
|
September 29, 2019
IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation
Jeanne Allinne, George Scott, Wei Keat Lim, et al.
Allergy
|
October 17, 2024
The IL-4-IL-4Rα axis modulates olfactory neuroimmune signaling to induce loss of smell
Yannis Hara, Mithilesh Kumar Jha, Jeremy Y Huang, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
November 9, 2020
Dupilumab Significantly Modulates Pain and Discomfort in Patients With Atopic Dermatitis: A Post Hoc Analysis of 5 Randomized Clinical Trials
Jonathan I Silverberg, Eric L Simpson, Emma Guttman-Yassky, et al.
Allergy
|
December 16, 2019
Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation
Audrey Le Floc'h, Jeanne Allinne, Kirsten Nagashima, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Nature Communications
|
December 23, 2025
IL-33 expands plasma cells, disrupts germinal centers, and increases autoantibody production in mice
Eva Conde, Seblewongel Asrat, Andrea Vecchione, et al.
Cell Reports Methods
|
August 3, 2023
TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells
Seblewongel Asrat, Joseph C Devlin, Andrea Vecchione, et al.
Science Immunology
|
September 6, 2024
IgE plasma cells are transcriptionally and functionally distinct from other isotypes
Andrea Vecchione, Joseph C Devlin, Carley Tasker, et al.
Cytokine
|
December 8, 2022
IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline
George Scott, Seblewongel Asrat, Jeanne Allinne, et al.
Allergy
|
January 27, 2024
Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy
Matthew F Wipperman, Kaitlyn M Gayvert, Amanda Atanasio, et al.
The Journal of Allergy and Clinical Immunology
|
August 7, 2022
REGN1908/1909 prevented cat allergen-induced early asthmatic responses in an environmental exposure unit
Frederic J de Blay, Alina Gherasim, Nathalie Domis, et al.
The Journal of Allergy and Clinical Immunology
|
September 29, 2019
IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation
Jeanne Allinne, George Scott, Wei Keat Lim, et al.
Allergy
|
October 17, 2024
The IL-4-IL-4Rα axis modulates olfactory neuroimmune signaling to induce loss of smell
Yannis Hara, Mithilesh Kumar Jha, Jeremy Y Huang, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
November 9, 2020
Dupilumab Significantly Modulates Pain and Discomfort in Patients With Atopic Dermatitis: A Post Hoc Analysis of 5 Randomized Clinical Trials
Jonathan I Silverberg, Eric L Simpson, Emma Guttman-Yassky, et al.
Allergy
|
December 16, 2019
Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation
Audrey Le Floc'h, Jeanne Allinne, Kirsten Nagashima, et al.
Page
of 3